Evaluation of a new training program to reassure primary school teachers about glucagon injection in children with type 1 diabetes during the 2017-2018 school year

What Was Tested

The paper reports a study of Glucagon, published as a clinical trial.

Adequate knowledge and skills of primary school staff are required to deal with children affected by T1D.

Who Took Part

By PubMed's age tags, the people studied were children, adults and middle-aged adults, both men and women.

In this interventional study, the researchers submitted a VTP to all primary school teachers in the French region of Normandy who received a child with T1D during the 2017-2018 school year.

How the Study Was Run

The VTP began with a questionnaire focused on their confidence in performing T1D-related actions and on their theoretical knowledge.

Next, the researchers offered a 10-min video covering the main issues of T1D, which could be watched freely for a fortnight.

The questionnaire was subsequently resubmitted.

The level of confidence was assessed on a scale of 1 to 4.

Knowledge was assessed as a score out of 20.

What Was Measured

Before-after comparisons were made using the Wilcoxon signed-rank test.

Determinants of a good level of confidence and knowledge before VTP were assessed in the first questionnaires using multivariate analysis.

The subject headings attached to it are Diabetes Mellitus, Type 1, France, Glucagon, Health Knowledge, Attitudes, Practice, Hormones, Hypoglycemia and Injections.

Author keywords: Glucagon/therapeutic use, School teachers, Training programs and Type 1 diabetes mellitus.

What This Means in Plain Language

This is a clinical trial of Glucagon.

The abstract goes on to report its results in about 4 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2020 (Archives de pediatrie : organe officiel de la Societe francaise de pediatrie), a journal based in France.

More context: the Glucagon compound page, all human trials.